Faculty

Back to Index
Uri Elkayam, MD
Clinical Professor of Medicine (Part Time)
Medicine
IRD 331 Off Campus Los Angeles
+1 323 226 7541

Overview

Uri Elkayam, MD is a Professor of Medicine and a Professor of Obstetrics and Gynecology at the University of Southern California. He is a nationally and internationally known expert in heart failure and heart disease in pregnancy. Dr Elkayam is a past member of the executive council of the Heart Failure Society of America and the chairman of its corporate affairs committee. He is a present or past editorial board member of the Journal of the American College of Cardiology , American Journal of Cardiology, Journal of Cardiac Failure, Heart Failure, Heart Failure Reviews, Journal of Preventive Cardiology and Cardiology in Review.

Awards

Department of Maternal- Fetal Medicine, USC Women's & Children's Hospital : Award for Education of Residents and Fellows, 2002

8th World Congress on Heart Failure : Melvin L. Marcus Memorial Award for Distinguished Contribution as a Gifted Teacher, 2002

International Academy of Cardiology: Distinguished Fellowship Award- Cardiology, 2007

Publications

Liu S, Elkayam U, Naqvi TZ. Echocardiography in Pregnancy: Part 1. Curr Cardiol Rep. 2016 Sep; 18(9):92. View in: PubMed

Narayanan M, Elkayam U, Naqvi TZ. Echocardiography in Pregnancy: Part 2. Curr Cardiol Rep. 2016 Sep; 18(9):90. View in: PubMed

Arany Z, Elkayam U. Response by Arany and Elkayam to Letter Regarding Article, "Peripartum Cardiomyopathy". Circulation. 2016 Aug 16; 134(7):e83-4. View in: PubMed

Elkayam U, Goland S, Pieper PG, Silverside CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol. 2016 Jul 26; 68(4):396-410. View in: PubMed

Ng TM, Goland S, Elkayam U. Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical Evidence. Cardiol Rev. 2016 Jul-Aug; 24(4):194-204. View in: PubMed

Elkayam U, Habakuk O. The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy? JACC Heart Fail. 2016 May; 4(5):389-91. View in: PubMed

Arany Z, Elkayam U. Peripartum Cardiomyopathy. Circulation. 2016 Apr 5; 133(14):1397-409. View in: PubMed

Sheppard R, Hsich E, Damp J, Elkayam U, Kealey A, Ramani G, Zucker M, Alexis JD, Horne BD, Hanley-Yanez K, Pisarcik J, Halder I, Fett JD, McNamara DM. GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study. Circ Heart Fail. 2016 Mar; 9(3):e002683. View in: PubMed

McNamara DM, Elkayam U, Cooper L, Fett JD. Reply: Comparison of the American PPCM Registry Data With International Registries. J Am Coll Cardiol. 2016 Feb 16; 67(6):734-5. View in: PubMed

McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J, Markham DW, Marek J, Gorcsan J, Wu WC, Lin Y, Halder I, Pisarcik J, Cooper LT, Fett JD. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015 Aug 25; 66(8):905-14. View in: PubMed

Goland S, Elkayam U. "Of mice and (wo)men": The need to confirm results of animal experimentations with solid clinical data. Trends Cardiovasc Med. 2015 Aug; 25(6):505-7. View in: PubMed

Kazory A, Elkayam U. Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies. J Card Fail. 2014 Dec; 20(12):1004-11. View in: PubMed

Ruys TP, Maggioni A, Johnson MR, Sliwa K, Tavazzi L, Schwerzmann M, Nihoyannopoulos P, Kozelj M, Marelli A, Elkayam U, Hall R, Roos-Hesselink JW. Cardiac medication during pregnancy, data from the ROPAC. Int J Cardiol. 2014 Nov 15; 177(1):124-8. View in: PubMed

Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol. 2014 Oct 14; 64(15):1629-36. View in: PubMed

Goland S, Schwartzenberg S, Fan J, Kozak N, Khatri N, Elkayam U. Monitoring of anti-xa in pregnant patients with mechanical prosthetic valves receiving low-molecular-weight heparin: peak or trough levels? J Cardiovasc Pharmacol Ther. 2014 Sep; 19(5):451-6. View in: PubMed

Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, Feldman AM, McNamara D, Leggett C. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. Am J Cardiol. 2014 Jul 1; 114(1):151-9. View in: PubMed

Sliwa K, Hilfiker-Kleiner D, Mebazaa A, Petrie MC, Maggioni AP, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Roos-Hesslink JW, Shah AJ, Seferovic PM, Elkayam U, van Spaendonck-Zwarts K, Bachelier-Walenta K, Mouquet F, Kraigher-Krainer E, Hall R, Ponikowski P, McMurray JJ, Pieske B. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail. 2014 May; 16(5):583-91. View in: PubMed

Elkayam U, Jalnapurkar S, Barakkat MN, Khatri N, Kealey AJ, Mehra A, Roth A. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation. 2014 Apr 22; 129(16):1695-702. View in: PubMed

Gleicher N, Elkayam U. Some more on preventing congenital heart block. Autoimmun Rev. 2014 Jan; 13(1):73-4. View in: PubMed

Ng TM, Cao DX, Patel KA, Wong YM, Prasad M, Lou M, Elkayam U. Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure. Cardiology. 2014; 128(4):333-42. View in: PubMed

Gleicher N, Elkayam U. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Autoimmun Rev. 2013 Sep; 12(11):1039-45. View in: PubMed

Packer M, Carson P, Elkayam U, Konstam MA, Moe G, O'Connor C, Rouleau JL, Schocken D, Anderson SA, Demets DL. Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy: Results of the PRAISE-2 Study (Prospective Randomized Amlodipine Survival Evaluation 2). JACC Heart Fail. 2013 Aug; 1(4):308-14. View in: PubMed

Ng TM, Konopka E, Hyderi AF, Hshieh S, Tsuji Y, Kim BJ, Han SY, Phan DH, Jeng AI, Lou M, Elkayam U. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther. 2013 Jul; 18(4):345-53. View in: PubMed

Schwartzenberg S, Perlman S, Levy R, Elkayam U, Goland S. Mechanical heart valve thrombosis in pregnancy. J Heart Valve Dis. 2013 Jul; 22(4):603-6. View in: PubMed

Goland S, Modi K, Hatamizadeh P, Elkayam U. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail. 2013 Apr; 19(4):214-8. View in: PubMed

Colletti PM, Lee KH, Elkayam U. Cardiovascular imaging of the pregnant patient. AJR Am J Roentgenol. 2013 Mar; 200(3):515-21. View in: PubMed

Ng TM, Hshieh S, Chan CY, Elkayam U. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. J Cardiovasc Pharmacol Ther. 2012 Dec; 17(4):373-81. View in: PubMed

Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012 Aug; 30(3):317-29. View in: PubMed

Elkayam U, Jalnapurkar S, Barakat M. Peripartum cardiomyopathy. Cardiol Clin. 2012 Aug; 30(3):435-40. View in: PubMed

Frishman WH, Elkayam U, Aronow WS. Cardiovascular drugs in pregnancy. Cardiol Clin. 2012 Aug; 30(3):463-91. View in: PubMed

Sahni G, Elkayam U. Cardiovascular disease in pregnancy. Cardiol Clin. 2012 Aug; 30(3):xi-xii. View in: PubMed

Goland S, Elkayam U. Anticoagulation in pregnancy. Cardiol Clin. 2012 Aug; 30(3):395-405. View in: PubMed

Naqvi TZ, Elkayam U. Serial echocardiographic assessment of the human heart in normal pregnancy. Circ Cardiovasc Imaging. 2012 May 1; 5(3):283-5. View in: PubMed

Elkayam U, Goland S. The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves. J Am Coll Cardiol. 2012 Mar 20; 59(12):1116-8. View in: PubMed

Ng TM, Ackerbauer KA, Hyderi AF, Hshieh S, Elkayam U. Comparative Effects of Nesiritide and Nitroglycerin on Renal Function, and Incidence of Renal Injury by Traditional and RIFLE Criteria in Acute Heart Failure. J Cardiovasc Pharmacol Ther. 2012 Mar; 17(1):79-85. View in: PubMed

Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011 Aug 9; 58(7):659-70. View in: PubMed

Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, Khatri N, Elkayam U. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011 May; 17(5):426-30. View in: PubMed

Abraham WT, Aranda JM, Boehmer JP, Elkayam U, Gilbert EM, Gottlieb SS, Hasenfuss G, Kukin M, Lowes BD, O'Connell JB, Tavazzi L, Feldman AM, Ticho B, Orlandi C. Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study. Clin Transl Sci. 2010 Oct; 3(5):249-53. View in: PubMed

Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010 Aug; 12(8):767-78. View in: PubMed

Giles TD, Elkayam U, Bhattacharya M, Perez A, Miller AB. Comparison of pioglitazone vs glyburide in early heart failure: insights from a randomized controlled study of patients with type 2 diabetes and mild cardiac disease. Congest Heart Fail. 2010 May-Jun; 16(3):111-7. View in: PubMed

Elkayam U, Goland S. Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation. 2010 Apr 6; 121(13):1463-4. View in: PubMed

Goland S, Tsai F, Habib M, Janmohamed M, Goodwin TM, Elkayam U. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension. Cardiology. 2010; 115(3):205-8. View in: PubMed

Ng TM, Tsai F, Khatri N, Barakat MN, Elkayam U. Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention. Circ Heart Fail. 2010 Jan; 3(1):165-73. View in: PubMed

Sarma RJ, Chana A, Elkayam U. Left ventricular noncompaction. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):264-73. View in: PubMed

Falk RH, Elkayam U. Cardiomyopathy: the importance of recognizing the uncommon diagnosis. Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4):262-3. View in: PubMed

Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009 Dec; 30(24):3015-26. View in: PubMed

Goland S, Barakat M, Khatri N, Elkayam U. Pregnancy in Marfan syndrome: maternal and fetal risk and recommendations for patient assessment and management. Cardiol Rev. 2009 Nov-Dec; 17(6):253-62. View in: PubMed

Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009 Oct; 15(8):645-50. View in: PubMed

Hameed AB, Chan K, Ghamsary M, Elkayam U. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol. 2009 Aug; 32(8):E60-2. View in: PubMed

Elkayam U. Beta-blockers in the treatment of aortic regurgitation a new opportunity? J Am Coll Cardiol. 2009 Jul 28; 54(5):458-9. View in: PubMed

Palardy M, Stevenson LW, Tasissa G, Hamilton MA, Bourge RC, Disalvo TG, Elkayam U, Hill JA, Reimold SC. Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial. Circ Heart Fail. 2009 May; 2(3):181-8. View in: PubMed

Elkayam U, Janmohamed M, Hatamizadeh P, Heywood JT, Wei LJ, Mills RM. Impact of acute serum creatinine elevation in patients treated with nesiritide. Clin Cardiol. 2009 Apr; 32(4):215-9. View in: PubMed

Gleicher N, Elkayam U. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev. 2009 Mar; 8(5):384-7. View in: PubMed

Goland S, Elkayam U. Cardiovascular problems in pregnant women with marfan syndrome. Circulation. 2009 Feb 3; 119(4):619-23. View in: PubMed

Elkayam U, Akhter MW, Liu M, Hatamizadeh P, Barakat MN. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography. JACC Cardiovasc Imaging. 2008 Nov; 1(6):765-71. View in: PubMed

Goldsmith SR, Elkayam U, Haught WH, Barve A, He W. Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study. J Card Fail. 2008 Oct; 14(8):641-7. View in: PubMed

Puri P, Mehra A, Elkayam U. Cheyne-Stokes respiration and cardiac hemodynamics in heart failure. Catheter Cardiovasc Interv. 2008 Oct 1; 72(4):581-5. View in: PubMed

Giles TD, Miller AB, Elkayam U, Bhattacharya M, Perez A. Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction. J Card Fail. 2008 Aug; 14(6):445-52. View in: PubMed

Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol. 2008 Jul 15; 52(3):171-80. View in: PubMed

Elkayam U, Janmohamed M, Habib M, Hatamizadeh P. Vasodilators in the management of acute heart failure. Crit Care Med. 2008 Jan; 36(1 Suppl):S95-105. View in: PubMed

Hameed AB, Goodwin TM, Elkayam U. Effect of pulmonary stenosis on pregnancy outcomes--a case-control study. Am Heart J. 2007 Nov; 154(5):852-4. View in: PubMed

Elkayam U, Hatamizadeh P, Janmohamed M. The challenge of correcting volume overload in hospitalized patients with decompensated heart failure. J Am Coll Cardiol. 2007 Feb 13; 49(6):684-6. View in: PubMed

Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J. 2007 Jan; 153(1):98-104. View in: PubMed

Payvar S, Orlandi C, Stough WG, Elkayam U, Ouyang J, Casscells SW, Gheorghiade M. Comparison of 60-day mortality in hospitalized heart failure patients with versus without hypothermia. Am J Cardiol. 2006 Dec 1; 98(11):1485-8. View in: PubMed

Bitar F, Lerman A, Akhter MW, Hatamizadeh P, Janmohamed M, Khan S, Elkayam U. Variable response of conductance and resistance coronary arteries to endothelial stimulation in patients with heart failure due to nonischemic dilated cardiomyopathy. J Cardiovasc Pharmacol Ther. 2006 Sep; 11(3):197-202. View in: PubMed

Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006 Aug 19; 368(9536):687-93. View in: PubMed

Tsai FS, Heidary S, Sarma R, Elkayam U. Safety of exercise testing in the chest pain unit: 31-mm ST elevation in variant angina. J Electrocardiol. 2006 Jul; 39(3):309. View in: PubMed

Elkayam U, Bitar F. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial. Am J Cardiol. 2005 Oct 10; 96(7B):37i-43i. View in: PubMed

Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol. 2005 Aug 2; 46(3):403-10. View in: PubMed

Hameed A, Akhter MW, Bitar F, Khan SA, Sarma R, Goodwin TM, Elkayam U. Left atrial thrombosis in pregnant women with mitral stenosis and sinus rhythm. Am J Obstet Gynecol. 2005 Aug; 193(2):501-4. View in: PubMed

Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005 Jul 19; 46(2):223-30. View in: PubMed

Seshadri N, Goldhaber SZ, Elkayam U, Grimm RA, Groce JB, Heit JA, Spinler SA, Turpie AG, Bosker G, Klein AL. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J. 2005 Jul; 150(1):27-34. View in: PubMed

Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005 Apr 26; 111(16):2050-5. View in: PubMed

Elkayam U. Letter regarding article by Wang et al, "nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine". Circulation. 2005 Apr 12; 111(14):e182-3; author reply e182-3. View in: PubMed

Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol. 2005 Jan 18; 45(2):252-9. View in: PubMed

Bitar F, Akhter MW, Khan S, Singh H, Elkayam U. Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States. Am J Cardiol. 2004 Dec 1; 94(11):1465-8. View in: PubMed

Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M. Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations. J Cardiovasc Pharmacol Ther. 2004 Dec; 9(4):227-41. View in: PubMed

Akhter MW, Aronson D, Bitar F, Khan S, Singh H, Singh RP, Burger AJ, Elkayam U. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol. 2004 Oct 1; 94(7):957-60. View in: PubMed

Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev. 2004 Sep-Oct; 12(5):240-61. View in: PubMed

Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev. 2004 Jul-Aug; 12(4):201-21. View in: PubMed

Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther. 2004 Jun; 9(2):107-15. View in: PubMed

Gheorghiade M, Gattis WA, O'Connor CM, Adams KF, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004 Apr 28; 291(16):1963-71. View in: PubMed

Elkayam U, Akhter MW, Singh H, Khan S, Usman A. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. Am J Cardiol. 2004 Jan 15; 93(2):237-40. View in: PubMed

Canetti M, Akhter MW, Lerman A, Karaalp IS, Zell JA, Singh H, Mehra A, Elkayam U. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol. 2003 Nov 15; 92(10):1246-9. View in: PubMed

Torre-Amione G, Young JB, Colucci WS, Lewis BS, Pratt C, Cotter G, Stangl K, Elkayam U, Teerlink JR, Frey A, Rainisio M, Kobrin I. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2003 Jul 2; 42(1):140-7. View in: PubMed

Gheorghiade M, Gattis WA, Barbagelata A, Adams KF, Elkayam U, Orlandi C, O'Connor CM. Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. Am Heart J. 2003 Feb; 145(2 Suppl):S51-4. View in: PubMed

Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002 Dec; 144(6):1102-8. View in: PubMed

Elkayam U, Akhter MW, Tummala P, Khan S, Singh H. Nesiritide: a new drug for the treatment of decompensated heart failure. J Cardiovasc Pharmacol Ther. 2002 Jul; 7(3):181-94. View in: PubMed

Silver MA, Horton DP, Ghali JK, Elkayam U. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 2002 Mar 6; 39(5):798-803. View in: PubMed

Elkayam U, Khan S, Mehboob A, Ahsan N. Impaired endothelium-mediated vasodilation in heart failure: clinical evidence and the potential for therapy. J Card Fail. 2002 Feb; 8(1):15-20. View in: PubMed

Powered bySC CTSI